NCT06201494 Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
| NCT ID | NCT06201494 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-01-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bronchial asthma may present with symptoms other than the commonly reported complaints (cough, chest tightness, shortness of breath and wheezing). Less common symptoms include chronic or recurrent productive cough, inspiratory dyspnoea or recurrent pneumonia. Children presenting with these symptoms are often diagnosed with asthma bronchiale and benefit from antiasthmatic management.
Eligibility Criteria
Inclusion Criteria: \- Child 3 - 18 years old, first evaluation in pulmonary outpatient clinic for any of the following respiratory symptoms: cough, shortness of breath, chest tightness, wheezing, recurrent lower respiratory tract and lung infections, dyspnoea of any type, pathological listening findings. Exclusion Criteria: * Other documented chronic respiratory, cardiovascular, neurological, genetic, infectious, metabolic disease, significant immaturity or other disease that may be accompanied by respiratory symptoms.
Contact & Investigator
Jana Tukova, MD,PhD
PRINCIPAL INVESTIGATOR
Charles University, Czech Republic First Faculty of Medicine, Prague
Frequently Asked Questions
Who can join the NCT06201494 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 18 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06201494 currently recruiting?
Yes, NCT06201494 is actively recruiting participants. Contact the research team at tukovajana@seznam.cz for enrollment information.
Where is the NCT06201494 trial being conducted?
This trial is being conducted at Prague, Czechia.
Who is sponsoring the NCT06201494 clinical trial?
NCT06201494 is sponsored by Charles University, Czech Republic. The principal investigator is Jana Tukova, MD,PhD at Charles University, Czech Republic First Faculty of Medicine, Prague. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.